JP2019533713A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019533713A5 JP2019533713A5 JP2019524887A JP2019524887A JP2019533713A5 JP 2019533713 A5 JP2019533713 A5 JP 2019533713A5 JP 2019524887 A JP2019524887 A JP 2019524887A JP 2019524887 A JP2019524887 A JP 2019524887A JP 2019533713 A5 JP2019533713 A5 JP 2019533713A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- pah
- riociguat
- sgc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022185917A JP2023029865A (ja) | 2016-11-10 | 2022-11-21 | ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法 |
| JP2025084398A JP2025131627A (ja) | 2016-11-10 | 2025-05-20 | ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662420515P | 2016-11-10 | 2016-11-10 | |
| US62/420,515 | 2016-11-10 | ||
| US201762530533P | 2017-07-10 | 2017-07-10 | |
| US62/530,533 | 2017-07-10 | ||
| PCT/US2017/061116 WO2018089804A1 (en) | 2016-11-10 | 2017-11-10 | Methods of treating pah with combinations of ralinepag and other agents |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022185917A Division JP2023029865A (ja) | 2016-11-10 | 2022-11-21 | ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019533713A JP2019533713A (ja) | 2019-11-21 |
| JP2019533713A5 true JP2019533713A5 (https=) | 2020-12-17 |
Family
ID=60451197
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019524887A Pending JP2019533713A (ja) | 2016-11-10 | 2017-11-10 | ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法 |
| JP2022185917A Pending JP2023029865A (ja) | 2016-11-10 | 2022-11-21 | ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法 |
| JP2025084398A Pending JP2025131627A (ja) | 2016-11-10 | 2025-05-20 | ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022185917A Pending JP2023029865A (ja) | 2016-11-10 | 2022-11-21 | ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法 |
| JP2025084398A Pending JP2025131627A (ja) | 2016-11-10 | 2025-05-20 | ラリンパグと他の薬剤とを組み合わせた肺動脈高血圧症を処置する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12377067B2 (https=) |
| EP (2) | EP4681708A3 (https=) |
| JP (3) | JP2019533713A (https=) |
| KR (4) | KR20260020212A (https=) |
| CN (2) | CN110691612B (https=) |
| AU (3) | AU2017357759A1 (https=) |
| CA (1) | CA3043283A1 (https=) |
| ES (1) | ES3052035T3 (https=) |
| IL (2) | IL266518B1 (https=) |
| MA (1) | MA46750A (https=) |
| WO (1) | WO2018089804A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20260020212A (ko) | 2016-11-10 | 2026-02-10 | 아레나 파마슈티칼스, 인크. | 라리네팍 및 다른 제제의 조합에 의한 pah의 치료 방법 |
| EP3977985B1 (en) | 2017-03-01 | 2023-09-06 | Arena Pharmaceuticals, Inc. | Compositions comprising pgi2-receptor agonists and processes for the preparation thereof |
| WO2019222764A1 (en) * | 2018-05-16 | 2019-11-21 | Arena Pharmaceuticals, Inc. | Compositions comprising pgi2-receptor agonists and processes for the preparation thereof |
| CN108721296B (zh) * | 2018-07-03 | 2019-04-05 | 中国人民解放军总医院 | 一种化合物在治疗或预防高原病中的用途 |
| CN112638865B (zh) * | 2018-09-06 | 2022-07-26 | 广东东阳光药业有限公司 | 药物共晶体及其制备方法 |
| CA3123990A1 (en) * | 2018-12-21 | 2020-06-25 | Actelion Pharmaceuticals Ltd | Pharmaceutical composition for the treatment of pulmonary arterial hypertension |
| TW202042818A (zh) * | 2019-01-25 | 2020-12-01 | 瑞士商艾克泰聯製藥有限公司 | 用於治療慢性血栓性肺高血壓之醫藥組成物 |
| US20230263807A1 (en) * | 2022-02-08 | 2023-08-24 | United Therapeutics Corporation | Treprostinil iloprost combination therapy |
| US12098116B2 (en) | 2022-02-15 | 2024-09-24 | United Therapeutics Corporation | Crystalline prostacyclin (IP) receptor agonist and uses thereof |
| US20250282716A1 (en) | 2024-03-11 | 2025-09-11 | United Therapeutics Corporation | Methods of making ip-receptor agonists |
| CN121714543A (zh) * | 2024-09-23 | 2026-03-24 | 上海欣药智能科技有限公司 | 一种可吸入的含可溶性鸟苷酸环化酶受体激动剂的药物组合物及其用途 |
| US12582629B1 (en) * | 2025-10-23 | 2026-03-24 | Innovate Therapeutics Llc | Extended-release pharmaceutical compositions of Ralinepag |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2085844A1 (en) | 1991-12-27 | 1993-06-28 | Nobuyuki Hamanaka | Fused benzeneoxyacetic acid derivatives |
| GB9908934D0 (en) | 1999-04-19 | 1999-06-16 | Rolic Ag | Liquid crystalline compounds |
| US20040048844A1 (en) | 1999-10-20 | 2004-03-11 | Bristol-Myers Squibb Pharma Company | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
| WO2002055484A1 (en) | 2001-01-12 | 2002-07-18 | Takeda Chemical Industries, Ltd. | Biaryl compound, process for producing the same, and agent |
| WO2003007888A2 (en) | 2001-07-20 | 2003-01-30 | Adipogenix, Inc. | Fat accumulation-modulating compounds |
| MXPA04001253A (es) | 2001-08-09 | 2004-06-03 | Ono Pharmaceutical Co | Derivados de acidos carboxilicos y agente farmaceutico que comprende los mismos como ingrediente activo. |
| TW200307539A (en) | 2002-02-01 | 2003-12-16 | Bristol Myers Squibb Co | Cycloalkyl inhibitors of potassium channel function |
| TWI293715B (en) | 2002-10-10 | 2008-02-21 | Sipix Imaging Inc | A method for inducing or enhancing the threshold of an electrophoretic display, an electrophoretic fluid and an electrophoretic display |
| CN101723891A (zh) | 2003-02-10 | 2010-06-09 | 沃泰克斯药物股份有限公司 | 通过使n-芳基氨基甲酸酯与卤代杂芳基反应制备n-杂芳基-n-芳基胺的方法和类似方法 |
| GB0325291D0 (en) | 2003-10-29 | 2003-12-03 | Pfizer Ltd | Novel combination |
| US20060063930A1 (en) | 2004-08-20 | 2006-03-23 | Agoston Gregory E | Compositions and methods comprising proteinase activated receptor antagonists |
| WO2007051255A1 (en) | 2005-11-04 | 2007-05-10 | The University Of Sydney | Process for the preparation of compounds containing an azacyclic ring system |
| CN101489544A (zh) | 2006-05-09 | 2009-07-22 | 海玛奎斯特医药公司 | 治疗血液病的方法 |
| KR20230085944A (ko) * | 2008-03-18 | 2023-06-14 | 아레나 파마슈티칼스, 인크. | 프로스타시클린 （ｐｇｉ２） 수용체와 관련된 장애의 치료에 유용한 상기 수용체의 조절제 |
| JP5603343B2 (ja) | 2008-11-26 | 2014-10-08 | アリーナ ファーマシューティカルズ， インコーポレイテッド | 関連する障害を処置するために有用なプロスタサイクリン（ｐｇｉ２）受容体モジュレーターとしてのピラゾリル置換炭酸誘導体 |
| PT2370413E (pt) | 2008-12-08 | 2015-10-23 | Arena Pharm Inc | Moduladores do recetor da prostaciclina (pgi2) úteis para o tratamento de distúrbios relacionados com o mesmo |
| EP2480526A1 (en) * | 2009-09-23 | 2012-08-01 | Arena Pharmaceuticals, Inc. | Crystalline forms and processes for the preparation of pgi2 receptor agonists |
| US9388154B2 (en) | 2011-09-12 | 2016-07-12 | Lund Biotechnology PBC | Process for preparing synthetic prostacyclins |
| AU2013351934B2 (en) * | 2012-11-30 | 2018-03-29 | Insmed Incorporated | Prostacylin compositions and methods for using the same |
| WO2016065103A1 (en) * | 2014-10-23 | 2016-04-28 | Arena Pharmaceuticals, Inc. | Method of treating conditions related to the pgi2 receptor |
| EP3244968B1 (en) * | 2015-01-13 | 2023-08-30 | Vivus LLC | Combination therapy for pulmonary hypertension |
| KR20260020212A (ko) | 2016-11-10 | 2026-02-10 | 아레나 파마슈티칼스, 인크. | 라리네팍 및 다른 제제의 조합에 의한 pah의 치료 방법 |
-
2017
- 2017-11-10 KR KR1020267001774A patent/KR20260020212A/ko active Pending
- 2017-11-10 US US16/348,665 patent/US12377067B2/en active Active
- 2017-11-10 JP JP2019524887A patent/JP2019533713A/ja active Pending
- 2017-11-10 CN CN201780082981.0A patent/CN110691612B/zh active Active
- 2017-11-10 CN CN202411493404.9A patent/CN119367341A/zh active Pending
- 2017-11-10 CA CA3043283A patent/CA3043283A1/en active Pending
- 2017-11-10 EP EP25199189.9A patent/EP4681708A3/en active Pending
- 2017-11-10 MA MA046750A patent/MA46750A/fr unknown
- 2017-11-10 KR KR1020247014676A patent/KR102916884B1/ko active Active
- 2017-11-10 ES ES17804042T patent/ES3052035T3/es active Active
- 2017-11-10 WO PCT/US2017/061116 patent/WO2018089804A1/en not_active Ceased
- 2017-11-10 KR KR1020197016623A patent/KR20200015439A/ko not_active Abandoned
- 2017-11-10 AU AU2017357759A patent/AU2017357759A1/en not_active Abandoned
- 2017-11-10 EP EP17804042.4A patent/EP3538154B1/en active Active
- 2017-11-10 KR KR1020237003653A patent/KR20230021186A/ko not_active Abandoned
-
2019
- 2019-05-08 IL IL266518A patent/IL266518B1/en unknown
-
2022
- 2022-11-21 JP JP2022185917A patent/JP2023029865A/ja active Pending
-
2023
- 2023-11-09 AU AU2023263497A patent/AU2023263497C1/en active Active
-
2025
- 2025-05-20 JP JP2025084398A patent/JP2025131627A/ja active Pending
- 2025-06-20 US US19/244,745 patent/US20260014114A1/en active Pending
- 2025-09-14 IL IL323354A patent/IL323354A/en unknown
- 2025-12-16 AU AU2025283444A patent/AU2025283444A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019533713A5 (https=) | ||
| JP2022058688A5 (https=) | ||
| JP2021098727A5 (https=) | ||
| JP2018193377A5 (https=) | ||
| JP2008505857A5 (https=) | ||
| JP2019081811A5 (https=) | ||
| KR20150132440A (ko) | 바이러스 감염의 치료제로서의 베라프로스트 이성질체 | |
| JP2017513809A5 (https=) | ||
| JP2006525328A5 (https=) | ||
| JP2021073257A5 (https=) | ||
| JP2009517411A5 (https=) | ||
| RU2016147008A (ru) | Жидкие композиции метформина с пролонгированным высвобождением | |
| JP2007513913A5 (https=) | ||
| JP2015522603A5 (https=) | ||
| JP2005535691A5 (https=) | ||
| JP2013528649A5 (https=) | ||
| JP2021516241A5 (https=) | ||
| JP2016501208A5 (https=) | ||
| Goldschmidt et al. | Compound cardiac toxicity of oral erythromycin and verapamil | |
| KR20110068985A (ko) | 변형 방출 라미프릴 조성물 및 그것의 사용 | |
| CN101642444B (zh) | 单硝酸异山梨酯双速渗透泵型控释制剂及其制备方法 | |
| RU2018104691A (ru) | Композиции с модифицированным высвобождением ницерголина | |
| CN101642443B (zh) | 单硝酸异山梨酯渗透泵型控释制剂及其制备方法 | |
| CN1224354A (zh) | 肺循环改善剂 | |
| JP2008543853A5 (https=) |